SCHEMBL9730610

SCHEMBL9730610

c1ccc2nc(-c3c[nH]nn3)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.46
NPC1 O15118 9/20 0.46
ALDH1A1 P00352 8/20 0.46
KDM4E B2RXH2 8/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
HSD17B10 Q99714 4/20 0.46
PKM P14618 4/20 0.46
HPGD P15428 4/20 0.46
TP53 P04637 3/20 0.46
ALOX15 P16050 2/20 0.46
TSHR P16473 1/20 0.46
AR P10275 6/20 0.46
CYP3A4 P08684 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28266911 0.98 RAB9A (0.45) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL29374931 0.79 RAB9A (0.64) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL170196 0.79 RAB9A (0.64) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL30883993 0.77 RAB9A (0.61) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL31243061 0.77 ALDH1A1 (0.63) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10866984 0.77 RAB9A (0.61) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL28990083 0.77 RAB9A (0.61) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL34463709 0.77 RAB9A (0.61) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL31490600 0.77 RAB9A (0.61) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL31365172 0.77 RAB9A (0.61) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1017244-B Process for preparing triazolyl quinoline derivatives ALKALOIDA WEGYESZETI GYAR (HU) 1992-07-01 CN claimed
US-5104884-A Rheumatic diseases, fungicides ALKALOIDA VEGYESZETI GYAR (HU) 1992-04-14 US claimed
EP-0221947-B1 TRIAZOLYL QUINOLINE DERIVATIVES ALKALOIDA VEGYéSZETI GYáR (HU) 1990-11-28 EP claimed
CN-86103997-A The preparation method of triazolyl quinoline derivative class 1987-12-30 CN claimed
EP-0221947-A1 TRIAZOLYL QUINOLINE DERIVATIVES. ALKALOIDA VEGYESZETI GYAR (HU) 1987-05-20 EP claimed
WO-1986006721-A1 TRIAZOLYL QUINOLINE DERIVATIVES ALKALOIDA VEGYÉSZETI GYÁR (HU) 1986-11-20 WO claimed
EP-4463230-A1 HALF-SANDWICH TRANSITION METAL COMPLEXES AND USES THEREOF Debreceni Egyetem (HU) 2024-11-20 EP disclosed
WO-2023041947-A1 HALF-SANDWICH TRANSITION METAL COMPLEXES AND USES THEREOF DEBRECENI EGYETEM (HU) 2023-03-23 WO disclosed
US-20210107896-A1 Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same UNIV YALE (US) 2021-04-15 US disclosed
US-10899739-B2 Macrophage migration inhibitory factor inhibitors, and methods of making and using same YALE UNIVERSITY (US) 2021-01-26 US disclosed
CN-108314647-B Preparation method of quinoline-2-formic acid and quinoline-2-formic acid derivative 华中科技大学 2020-06-26 CN disclosed
US-20190144424-A1 Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same YALE UNIVERSITY 2019-05-16 US disclosed
CN-109206405-A Triazolyl quinoline copper complex with AIE property and preparation method thereof 阜阳师范学院 2019-01-15 CN disclosed
EP-0221947-B1 TRIAZOLYL QUINOLINE DERIVATIVES ALKALOIDA VEGYéSZETI GYáR (HU) 1990-11-28 EP disclosed
CN-86103997-A The preparation method of triazolyl quinoline derivative class 1987-12-30 CN disclosed
CN-86103997-A The preparation method of triazolyl quinoline derivative class 1987-12-30 CN disclosed
EP-0221947-A1 TRIAZOLYL QUINOLINE DERIVATIVES. ALKALOIDA VEGYESZETI GYAR (HU) 1987-05-20 EP disclosed
EP-0221947-A1 TRIAZOLYL QUINOLINE DERIVATIVES. ALKALOIDA VEGYESZETI GYAR (HU) 1987-05-20 EP disclosed
WO-1986006721-A1 TRIAZOLYL QUINOLINE DERIVATIVES ALKALOIDA VEGYÉSZETI GYÁR (HU) 1986-11-20 WO disclosed
WO-1986006721-A1 TRIAZOLYL QUINOLINE DERIVATIVES ALKALOIDA VEGYÉSZETI GYÁR (HU) 1986-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210107896-A1 Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same MIF, MMP12, METAP1 RAB9A 4213/4885NPC1 4328/4885ALDH1A1 2061/4885
US-20190144424-A1 Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same MIF, MMP12, METAP1 RAB9A 4213/4885NPC1 4328/4885ALDH1A1 2061/4885
US-10899739-B2 Macrophage migration inhibitory factor inhibitors, and methods of making and using same MIF, MMP12, METAP1 RAB9A 4213/4885NPC1 4328/4885ALDH1A1 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.